ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

Therapies that target the EGF receptor (EGFR), such as gefitinib (IRESSA), are effective in a subset of patients with advanced non-small cell lung cancer (NSCLC). The differences in intracellular signaling networks between gefitinib-sensitive and -resistant NSCLCs remain poorly understood. In this s...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Engelman, Jeffrey A., Jänne, Pasi A., Mermel, Craig, Pearlberg, Joseph, Mukohara, Toru, Fleet, Christina, Cichowski, Karen, Johnson, Bruce E., Cantley, Lewis C.
Format: Artigo
Sprog:Inglês
Udgivet: National Academy of Sciences 2005
Fag:
Biological Sciences
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC553328/
https://ncbi.nlm.nih.gov/pubmed/15731348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0409773102
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker